The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
Items 501–600 of 638
Teng, Y., Bian, W., Li, Q., Eyk, J. E. V., Yan, X., & Zhang, S. Y. (2026) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2026-0043 · Cited by 3
Christa, M., Dithmar, F., Weinaus, T., Kohlhaas, M., Arias-Loza, P.-A., Hofmann, M., Elabyad, I. A., Gutjahr, F. T., Maack, C., & Bauer, W. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-52377-w · Cited by 3
Wang, L., Chen, S., Huang, X., Wu, Z., & Zhang, Q. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317498 · Cited by 3
Insights into Pulmonary Arterial Hypertension in Connective Tissue Diseases
Grygiel‐Górniak, B., Lucki, M., Daroszewski, P., & Lucka, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134742 · Cited by 3
Beaumont, J., González, A., López, B., Ravassa, S., & Dı́ez, J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834e4bb0 · Cited by 3
Inflammation in Heart Failure with Preserved Ejection Fraction
van Empel, V. P. M., & Rocca, H. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800039-7.00001-3 · Cited by 3
Cauwenberghs, N., Godderis, S., Sabovčik, F., Cornelissen, V., & Kuznetsova, T. (2021) · Microcirculation · doi:10.1111/micc.12731 · Cited by 3
Henry, J. P., Carlier, F. M., Higny, J., Benoît, M., Xhaët, O., Blommaert, D., Telbis, A.-M., Robaye, B., Gabriël, L., Guédès, A., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14131340 · Cited by 3
Zhang, S., Lin, Z., Yu, B., Liu, J., Jin, J., Li, G., & Dong, H. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04093-6 · Cited by 3
Novel Therapeutic Strategies Targeting Fibroblasts to Improve Heart Disease
Li, Y. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31504 · Cited by 4
Heart Failure in Rheumatic Disease
Løgstrup, B. B. (2022) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2022.08.003 · Cited by 3
Pentraxin 3 as a new biomarker of diastolic dysfunction
Liu, Q., Tu, T., Bai, Z., & Zhou, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.011 · Cited by 3
Remmelzwaal, S., Beulens, J. W. J., Elders, P. J. M., Stehouwer, C. D. A., Zhang, Z., Handoko, M. L., Appelman, Y., van Empel, V. P. M., Heymans, S. R. B., Thijs, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251148 · Cited by 3
Sex Specific Mechanisms of Myocardial Hypertrophy and Heart Failure
Regitz‐Zagrosek, V., Ventura‐Clapier, R., den Ruijter, H. M., Garnier, A., Barcena, M. L., Eikendal, A. L. M., & Hartman, R. J. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00017-8 · Cited by 3
Heng, Z., Hong, M., Zhang, Z., Ye, X., Zhou, J., Wu, W., Rong, J., & Xu, Y. (2025) · Advanced Science · doi:10.1002/advs.202507554 · Cited by 2
Cardiovascular rehabilitation in rheumatoid arthritis: evidence and future directions
Alnaimat, F., Ghazzal, H., Kajjoun, G., Kajjoun, F., Mutalipova, G., & Imanbayeva, N. (2025) · Rheumatology International · doi:10.1007/s00296-025-06055-3 · Cited by 2
Ob, K., Викторович, Ж. В., Васильевич, Б. В., & Викторовна, Б. Н. (2018) · Kardiologiia · doi:10.18087/cardio.2451 · Cited by 2
FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
Makrutzki-Zlotek, K., Escher, F., Karadeniz, Z., Aleshcheva, G., Pietsch, H., Küchler, K., Schultheiß, H., Heidecker, B., Poller, W. C., Landmesser, U., et al. (2023) · Heart · doi:10.1136/heartjnl-2022-321732 · Cited by 2
Self-citationTan, X., Wang, J., Liu, X., Xie, G., & Ouyang, F. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23707 · Cited by 2
Rate Versus Rhythm Control for Atrial Fibrillation with Heart Failure
Saksena, S. V., & Slee, A. E. (2024) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2024.09.002 · Cited by 2
Guajardo-Jauregui, N., la Garza, J. A. C., Galarza-Delgado, D. Á., Azpiri-Lopez, J. R., Arvizu‐Rivera, R. I., Polina-Lugo, R. L., & Colunga-Pedraza, I. J. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07249-z · Cited by 2
Heart failure with preserved ejection fraction
van Heerebeek, L., & Paulus, W. J. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780198766223.003.0029 · Cited by 2
TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model
Shen, X., Li, W., Jiang, X., Wen, H., Shen, Y., Zhang, W., Peng, Y., & Kang, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328981 · Cited by 2
Papagiannis, A., Alkagiet, S., & Τζιόμαλος, Κ. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190219140342 · Cited by 2
Neue Therapiekonzepte zur Herzinsuffizienz mit erhaltener Ejektionsfraktion
Tschöpe, C., & Pieske, B. M. (2015) · Herz · doi:10.1007/s00059-015-4210-x · Cited by 2
Self-citationRôle des intégrines dans la fibrose cardiaque
Delacroix, C., & Hulot, J. (2022) · médecine/sciences · doi:10.1051/medsci/2022055 · Cited by 2
Haque, S. E., Khan, A. G., & Iqubal, A. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223941124010007 · Cited by 2
Albakri, A. (2018) · Internal Medicine and Care · doi:10.15761/imc.1000120 · Cited by 2
Potential of valsartan+sacubitril therapy in hypertensive heart disease
Ovchinnikov, A. G., Gvozdeva, A. D., Potekhina, A. V., Vitsenya, M. V., & Ageev, F. T. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4568 · Cited by 2
Aoki, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-1268 · Cited by 2
Heart Failure in Women: Is There a Typical Female Type?
Aizpurua, A. B., & van Empel, V. P. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-54960-6_6 · Cited by 1
Bräuninger, H., Kupsch, S., Haacke, V. K., Bacmeister, L., Weber, S., Hilgendorf, I., Keller, T., Dechend, R., Huber, T. B., Westermann, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30712-z · Cited by 1
Self-citationEchocardiographic predictors of futile recanalization in acute ischemic stroke
Ertuğrul, Ö. Z., Karaaslan, F., Yılmaz, R., & Tuncer, M. C. (2025) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20250918 · Cited by 1
Chen, C., Zhang, S. Y., Liu, Y., Zhao, L., Wang, Y., Li, Y., & Song, Q. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05836-3 · Cited by 1
Butler, J., Jamil, A., Cherney, D. Z. I., Jafar, T. H., Testani, J. M., & Khan, M. S. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag426 · Cited by 1
Pan, Y., Li, W.-H., Zhang, W., Ma, W., & Sun, H. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00599-x · Cited by 1
A critical role for IL-21/IL-21 receptor signaling in isoproterenol-induced cardiac remodeling
Qi, B., Xu, R., Jin, Y., Wang, Y., Cheng, T., Liu, C., Ji, Y., Guo, L., Li, J., Gao, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-02552-4 · Cited by 1
Filatova, A. Y., Ovchinnikov, A. G., Николаевна, С. О., Sobolevskaya, M. S., Gomyranova, N. V., & Arefieva, T. I. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6569 · Cited by 1
Roy, A.-S., Jolicoeur, M. E., Bérubé, L., Forcillo, J., Pacheco, C., Potter, B. J., Pelletier‐Galarneau, M., & Bouabdallaoui, N. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10661-z · Cited by 1
Diabetic Cardiomyopathy: Distinct Clinical Entity or Manifestation of Metabolic Heart Disease?
D’Elia, S., Franzese, R., Luisi, E., Morello, M., Titolo, G., Serpico, C., Solimene, A., Granata, M., Acampora, B., Loffredo, F. S., et al. (2026) · Diabetology · doi:10.3390/diabetology7080160 · Cited by 1
Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation
Jaeschke, L., Koçana, C., Chitroceanu, A. M., Winkler, A., Kleitke, H., Fahjen, P., Kamp, J. J. P. V. D., Faidel, D., Asmus, E., Meiser, M., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078476 · Cited by 1
Firefighting in viral myocarditis — Extinguish galectin-3 to control the inflamed heart?
Lindner, D., & Westermann, D. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.06.004 · Cited by 1
Self-citationKrüger, W. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-54973-6_2 · Cited by 1
Circulation: Heart Failure Editors' Picks
Kociol, R. D. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967463 · Cited by 1
Bedel, C., Selvi, F., Zortuk, Ö., Yıldız, G., Yavuz, Y. F., & Korkut, M. (2024) · Revista română de medicină de laborator · doi:10.2478/rrlm-2024-0015 · Cited by 1
Abraham, J. D., Shavik, S. M., Mitchell, T. R., Lee, L. C., Ray, B., & Leonardi, C. R. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109019 · Cited by 1
Vereckei, A. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30306 · Cited by 1
Falla cardiaca con fracción de eyección preservada: un problema de la cardiología contemporánea
Saldarriaga, C., Ramirez-Ramos, C. F., Gallego, C., Castilla-Agudelo, G. A., Aranzazu-Uribe, M., & Betancur, S. S. (2020) · Archivos Peruanos de Cardiología y Cirugía Cardiovascular · doi:10.47487/apcyccv.v1i2.53 · Cited by 1
Alterations in Ventricular Function
van Heerebeek, L., & Paulus, W. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00011-9 · Cited by 1
Tie, H., Welp, H. A., Martens, S., Seiler, M., Albers, P., Mueller, K.-M., Li, Z., & Martens, S. (2021) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivab180 · Cited by 1
Myocardial Basis for Heart Failure
Spinale, F. G., Oatmen, K. E., & Sapp, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00004-1 · Cited by 1
Cardiac Microvascular Endothelial Cells and Pressure Overload-Induced Cardiac Fibrosis
Al‐Hasani, J., & Hecker, M. (2023) · Cardiac and vascular biology · doi:10.1007/978-3-031-23965-6_10 · Cited by 1
ZAKHARYAN, E. A., & Ushakov, A. V. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3776 · Cited by 1
Sex and Gender Differences in Cardiovascular Disease
Mathews, L. M., Chandrashekar, P., Prasad, M., Miller, V. M., Sharma, K., Sedlak, T., Merz, C. N. B., & Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.64153-4 · Cited by 1
Coordinate Targeting of Mitochondrial Energetics, Antioxidant Defenses, and Inflammation
Sack, M. N. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.02.013 · Cited by 1
Buglione, A. E., Small, D. M., Allan‐Rahill, N. H., Locke, T., Elmagid, L. M. A., Kim, R., Hovasapian, S., Mistry, A. A., Vaquerano, S. A., Schaffer, C. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.17.638717 · Cited by 1
Takawale, A. R., Shen, M., Dong, F., & Kassiri, Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-17437-2_12
Patogênese da endomiocardiofibrose: perfil imunológico e análise proteômica de tecido cardíaco
Bossa, A. S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-17102013-121601
Role of inflammation and extracellular matrix remodelling in dogs with cardiac and systemic diseases
Fonfara, S. (2013) · Työväentutkimus Vuosikirja
Regulation of cardiac fibrosis by class l histone deacetylases
Williams, S. M. (2012) · doi:10.25677/tdg0-0302
Tissue Characterisation in Acquired Heart Disease with Cardiovascular Magnetic Resonance Imaging
McDiarmid, A. K. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Kašner, M. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14422
Involvement of bone morphogenetic protein-binding endothelial regulator in aortic valve stenosis
Sawada, H., Naito, Y., Hirotani, S., Akahori, H., Iwasaku, T., Eguchi, A., Okuhara, Y., Fujii, A., Ohyanagi, M., Mitsuno, M., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.013
Dı́ez, J. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.07.005
Biomarker Testing and Pre-emptive Therapy in Preventing Heart Failure
McDonald, K., Ledwidge, M. T., Gallagher, J., & Watson, C. J. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0456-3
Aging and Diastolic Dysfunction: The Interplay of Inflammation and Extracellular Matrix Regulation
Becher, P. M., Westermann, D., & Tschöpe, C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_13
Self-citationDalva, M. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-05042012-085911
Monopoli, D. E., Modena, M. G., & Sangiorgi, G. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.054
The role of relaxin in left ventricular fibrosis: Endogenous expression and therapeutic potential
Haney, J. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Towards ‘Eternal Youth’ of cardiac and skeletal muscle
Yacoub, M. H., & ElGuindy, A. M. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.12
Cogswell, R. J., & Thenappan, T. (2015) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-14.2.88
Heart Failure with Normal Left Ventricular Ejection Fraction (HFNEF)
Krüger, W. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-54973-6_5
Circulation: Cardiovascular Imaging Editors’ Picks
Editors, T. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.980094
Evolving Concepts on the Basic Mechanisms of Heart Failure
Dorobanţu, M., & Onciul, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-45237-1_2
OBSOLETE: Sex and Gender Differences in Cardiovascular Disease
Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64153-3
de Denus, S., Lavoie, J., Ducharme, A., Sirois, M. G., Neagoe, P., Zhu, L., Rouleau, J. L., & White, M. (2012)
Calvo, B. M., Martínez, A., Orgil, S. L., López‐Andrés, N., Román-García, F., Palomares, V. V., de la Villa, E. D. L. C., Patiño, V., & Arribas-Gómez, I. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.04.006
Calvo, B. M., Martínez, A., Orgil, S. L., López‐Andrés, N., Román-García, F., Palomares, V. V., de la Villa, E. D. L. C., Patiño, V., & Arribas-Gómez, I. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.04.012
CPCs and ECM: A Good Mix for Cardiac Regeneration
Picchio, V., Raimo, T. D., & Angelini, F. (2018) · Med One · doi:10.20900/mo.20180014
How does the Extracellular Matrix Change in the Setting of Heart Failure?
Argyriou, A. (2018) · International Journal of Medical Students · doi:10.5195/ijms.2018.299
The Research Progress of Cardiac Implantable Electronic Device-Identified Atrial Fibrillation
卢, 江. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.103036
Krisai, P., Hämmerle, P., Blum, S., Meyre, P. B., Aeschbacher, S., Melchiorre, P. A. M., Baretella, O., Rodondi, N., Conen, D., Osswald, S., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13168
A novel paradigm for heart failure with preserved ejection fraction
Cuijpers, I. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201028ic
Skybchyk, V. А., & Melen, Y. P. (2016) · Medicine of Ukraine · doi:10.37987/1997-9894.2016.3(199).203539
Bhat, P., & Tang, W. H. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64067-1.00036-x
Korosoglou, G., & Haass, M. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02301-4
Circulation: Cardiovascular Imaging Editors’ Picks
Editors, T. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.978148
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.139808
Circulation: Heart Failure Editors' Picks
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.128405
Correlation Studies of Serum 25-(OH)D, FIB, MPV/PLT Levels and Chronic Heart Failure
胡, 菲. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125597
Obesity, inflammation, and cardiovascular disorders
Ehsan, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90960-0.00013-8
Atrial fibrillation and hypercoagulability
Scaf, B. (2022) · doi:10.26481/dis.20221020ed
Moreyra, C., Moreyra, E. A., & Rozich, J. D. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000494
Caiati, C., & Jirillo, E. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230911141418
Duchatsch, F., Miotto, D. S., Tardelli, L. P., Dionísio, T. J., Campos, D. S., Santos, C. F., Okoshi, K., & Amaral, S. L. (2023) · Biomedicines · doi:10.3390/biomedicines11123219
Pyvovar, S. M., Rudyk, I. S., & Shcherban, T. D. (2024) · Wiadomości Lekarskie · doi:10.36740/wlek202401113
Wollmann, C. A. R., Freire, E. M., de Almeida, E. B., de Camargo, G. L., Filho, G. S. L. S., Borges, H. D. S., Ferreira, P. C. D. L., & Faria, T. M. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024264p575
Expanding the horizon of heart failure with Preserved Ejection Fraction (HFPEF)
Weerts, J. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240626jw
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review